Alert icon
We're changing our privacy policy. This stuff matters.  Learn more  Dismiss

AACR: Molecule Promising Against Basal Cell Carcinoma

Loading...

Sign in or sign up now!
765 views
Loading...
Alert icon
Sign in or sign up now!
Alert icon

Uploaded by on Apr 18, 2008

http://www.medpagetoday.com
Daniel Von Hoff, M.D., of the Scottsdale Clinical Research Institute in Arizona

SAN DIEGO, April 15 -- Eight of nine patients with metastatic basal cell carcinoma had durable clinical benefit with minimal toxicity when treated with an investigational compound that inhibits signaling in the Hedgehog pathway.

Category:

Education

Tags:

License:

Standard YouTube License

  • likes, 0 dislikes

Link to this comment:

Share to:
see all

All Comments (1)

Sign In or Sign Up now to post a comment!
  • The spokesperson said, 'GDC-0499..."IT IS GDC-0449' BY GENENTECH LABS. DR. ERVIN EPSTEIN IN OAKLAND, CA IS ALSO WORKING WITH DR. VON HOFF ON THIS. I KNOW, I WAS SUPPOSED TO BE ONE OF THE FIRST PATEINTS. I HAVE GORLIN-GOLTZ SYNDROME. THOUSANDS OF BASAL CELL CARCINOMA'S. USING EFUDEX WAS HORRIFIC AND BURNED MY SKIN

Loading...

0 / 00Unsaved Playlist Return to active list
    1. Your queue is empty. Add videos to your queue using this button:
      or sign in to load a different list.
    Loading...Loading...Saving...
    • Clear all videos from this list
    • Learn more